Paper6984352
Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF).
Kedar E and 3 others. Cancer Immunol Immunother, 1982. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF). Papers, record 6984352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6984352
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF).
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| Immunotherapy | Major topic |
| Interleukin-2 | Major topic |
| Lung Neoplasms | Major topic |
| Mammary Neoplasms, Experimental | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Cell Line | |
| Cells, Cultured | |
| Drug Evaluation, Preclinical | |
| Female | |
| Humans | |
| Male | |
| Mice | |
| Mice, Inbred Strains | |
| Neoplasms | |
| Neoplasms, Experimental | |
| Rosette Formation |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6968245 | In vitro growth of murine T cells. IV. Use of T-cell growth factor to clone lymphoid cells. | Cell Immunol | 1980 | https://conductscience.org/library/papers/6968245 | PubMed |
| 2 | 6984388 | A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses. | Eur J Cancer Clin Oncol | 1982 | https://conductscience.org/library/papers/6984388 | PubMed |
| 3 | 6989911 | In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells. | J Immunol | 1980 | https://conductscience.org/library/papers/6989911 | PubMed |
| 4 | 224318 | Continuous culture of T cells cytotoxic for autologous human leukaemia cells. | Nature | 1979 | https://conductscience.org/library/papers/224318 | PubMed |
| 5 | 6164729 | Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. | J Immunol | 1981 | https://conductscience.org/library/papers/6164729 | PubMed |
| 6 | 309484 | In vitro growth of murine T cells. I. Production of factors necessary for T cell growth. | J Immunol | 1978 | https://conductscience.org/library/papers/309484 | PubMed |
| 7 | 6966652 | In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors. | J Immunol | 1980 | https://conductscience.org/library/papers/6966652 | PubMed |
| 8 | 376742 | Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations. | J Immunol | 1979 | https://conductscience.org/library/papers/376742 | PubMed |
| 9 | 6165306 | Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages. | Ann N Y Acad Sci | 1980 | https://conductscience.org/library/papers/6165306 | PubMed |
| 10 | 6154658 | In vivo natural reactivity of mice against tumor cells. | Int J Cancer | 1980 | https://conductscience.org/library/papers/6154658 | PubMed |
| 11 | 6168724 | On the heterogeneity of murine natural killer cells. | J Exp Med | 1981 | https://conductscience.org/library/papers/6168724 | PubMed |
| 12 | 368247 | Evaluation of the role of IgG antibodies in human natural cell-mediated cytotoxicity against the myeloid cell line K562. | J Immunol | 1979 | https://conductscience.org/library/papers/368247 | PubMed |
| 13 | 6161166 | Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens. | J Immunol | 1981 | https://conductscience.org/library/papers/6161166 | PubMed |
| 14 | 6166701 | Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. | J Exp Med | 1981 | https://conductscience.org/library/papers/6166701 | PubMed |
| 15 | 7252408 | Cloned cell lines with natural killer activity. Specificity, function, and cell surface markers. | J Exp Med | 1981 | https://conductscience.org/library/papers/7252408 | PubMed |
| 16 | 6448800 | Quantitation and cloning of cytolytic T lymphocytes and their precursors. | Immunol Rev | 1980 | https://conductscience.org/library/papers/6448800 | PubMed |
| 17 | 6459065 | Expansion of autorecognitive cytotoxic effectors in human cancer by T cell growth factor (Interleukin 2)1. | Arch Geschwulstforsch | 1981 | https://conductscience.org/library/papers/6459065 | PubMed |
| 18 | 307029 | T cell growth factor: parameters of production and a quantitative microassay for activity. | J Immunol | 1978 | https://conductscience.org/library/papers/307029 | PubMed |
| 19 | 7000675 | Clones of killer and helper T cells: growth requirements, specificity and retention of function in long-term culture. | Immunol Rev | 1980 | https://conductscience.org/library/papers/7000675 | PubMed |
| 20 | 145543 | Long term culture of tumour-specific cytotoxic T cells. | Nature | 1977 | https://conductscience.org/library/papers/145543 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24941370 | Natural killer activity: early days, advances, and seminal observations. | Crit Rev Oncog | 2014 | https://conductscience.org/library/papers/24941370 | PubMed |
| 22484193 | Advances in the treatment of metastatic melanoma: adoptive T-cell therapy. | Semin Oncol | 2012 | https://conductscience.org/library/papers/22484193 | PubMed |
| 11122856 | Vaccination for melanoma. | Curr Oncol Rep | 2000 | https://conductscience.org/library/papers/11122856 | PubMed |
| 6850100 | Large granular lymphocytes: morphological and functional properties. I. Results in normals. | Blut | 1983 | https://conductscience.org/library/papers/6850100 | PubMed |
| 6386143 | Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines. | Cancer Metastasis Rev | 1984 | https://conductscience.org/library/papers/6386143 | PubMed |
| 6375859 | Natural killer cells: artifact to reality: an odyssey in biology. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6375859 | PubMed |
| 6334553 | Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6334553 | PubMed |
| 6239683 | Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6239683 | PubMed |
| 6141211 | Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2. | J Exp Med | 1984 | https://conductscience.org/library/papers/6141211 | PubMed |
| 3873352 | Natural killer-like activity in human cultured lymphoid cells propagated in the presence of interleukin-2: acquired resistance to prostaglandin E2- or dexamethasone-mediated suppression. | Experientia | 1985 | https://conductscience.org/library/papers/3873352 | PubMed |
| 3488319 | In vivo augmentation of the cytotoxicity of spleen lymphocytes against syngeneic B-16 melanoma cells and the suppression of the artificial metastases in C57BL/6 mice by subcutaneous multiple injections of high dose human recombinant interleukin-2 (rIL-2). | J Cancer Res Clin Oncol | 1986 | https://conductscience.org/library/papers/3488319 | PubMed |
| 3486715 | Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3486715 | PubMed |
| 2676022 | Lymphokine activated killer cells. | Blut | 1989 | https://conductscience.org/library/papers/2676022 | PubMed |
| 2425968 | Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/2425968 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6984352
GET https://conductscience.org/api/papers/v1/6984352/references?page=2